Core Insights - Humanoid Global Holdings Corp. is focused on building a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, with a recent update from RideScan Ltd highlighting significant advancements in technology and funding [1][6] Group 1: Patent and Technology Development - RideScan has filed a foundational patent application with the UK Intellectual Property Office to protect its unique approach to independent risk scoring and anomaly detection in robotics, which aims to enhance robotic safety and reliability [2] - The patent-pending technology is designed to support applications from mission-level risk assessment to proactive maintenance and certification [2] - RideScan is entering pilot deployments across various robotics ecosystems to demonstrate its ability to provide independent, AI-driven insights into robot health and performance [3] Group 2: Pilot Programs and Collaborations - RideScan is assembling a cohort of 10 organizations to integrate its API across different robotics platforms, aiming to reduce downtime and enhance operational safety through independent robotic health checks [4] - The cohort includes engineers and teams from research institutions and corporations in the robotics field, focusing on identifying issues before they escalate and uncovering hidden anomalies [4] Group 3: Funding and Financial Support - RideScan has been awarded £50,000 from the Innovate UK Growth Catalyst Early Stage: New Innovators grant to support the expansion and commercialization of its core technology, with execution starting on November 1, 2025 [5] - Additionally, RideScan has secured £40,000 from a Europe-based deep-tech-focused angel syndicate, which includes research scientists from a Fortune 500 company specializing in AI research [5]

Core Insights - Humanoid Global Holdings Corp. is focused on building a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, with a recent update from RideScan Ltd highlighting significant advancements in technology and funding [1][6] Group 1: Patent and Technology Development - RideScan has filed a foundational patent application with the UK Intellectual Property Office to protect its unique approach to independent risk scoring and anomaly detection in robotics, which aims to enhance robotic safety and reliability [2] - The patent-pending technology is designed to support applications from mission-level risk assessment to proactive maintenance and certification [2] - RideScan is entering pilot deployments across various robotics ecosystems to demonstrate its ability to provide independent, AI-driven insights into robot health and performance [3] Group 2: Pilot Programs and Collaborations - RideScan is assembling a cohort of 10 organizations to integrate its API across different robotics platforms, aiming to reduce downtime and enhance operational safety through independent robotic health checks [4] - The cohort includes engineers and teams from research institutions and corporations in the robotics field, focusing on identifying issues before they escalate and uncovering hidden anomalies [4] Group 3: Funding and Financial Support - RideScan has been awarded £50,000 from the Innovate UK Growth Catalyst Early Stage: New Innovators grant to support the expansion and commercialization of its core technology, with execution starting on November 1, 2025 [5] - Additionally, RideScan has secured £40,000 from a Europe-based deep-tech-focused angel syndicate, which includes research scientists from a Fortune 500 company specializing in AI research [5]